Clinical Trial Update: A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced. [NA]

View source ↗

Summary

A clinical study evaluating the safety and performance of PEEK-OPTIMA HA Enhanced sponsored by Invibio Ltd has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Retrolisthesis
• Spondylolisthesis

Drugs mentioned

• PEEK-OPTIMA HA Enhanced

Snippet

Sponsor: Invibio Ltd | Conditions: Degenerative Disc Disease, Spondylolisthesis | NA | Status: COMPLETED